Companies: 10,795·Total market cap: $144.5T

Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc.

GLUENASDAQHealthcare● Active

$16.84

+$0.47(+2.84%)

Market Cap$1.1B

P/E Ratio—

52W High$25.77

52W Low$4.12

Avg Volume993K

Open$16.56

Beta1.60

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Monte Rosa Therapeutics, Inc.（GLUE）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · GLUE · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-1.86Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$43.0MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding83.1MShares outstanding history

Next EarningsAug 6, 2026Est.Earnings history

探索 Monte Rosa Therapeutics, Inc. 数据

分析师预测$32 · Buy

股息不分红

营收$123.7M+63.54%

盈利EPS $-0.46+53.06%

财务快照

FY 2025Revenue$123.7M▲ +63.54% YoY

202320242025

FY 2025Net Income-$38.6M▲ +46.87% YoY

202320242025

FY 2025EPS$-0.46▲ +53.06% YoY

202320242025

TTM:Revenue: $43.0MNet Income: -$130.0MEPS: $-1.86View income statement →

分析师评级与目标价

Buy9 位分析师

Strong Buy

0

Buy

7

Hold

2

Sell

0

Strong Sell

0

12-Month Price Target

$22.00Low

$16.84Current

$31.75Avg Target上涨空间 88.60%

$37.00High

合计: 9 · 买入占比: 77.8%

根据过去 3 个月内 9 位华尔街分析师，GLUE 共识评级为 Buy，12 个月平均目标价 $31.75 （较现价 $16.84 上涨空间 88.60%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Monte Rosa Therapeutics, Inc.

$16.84+2.84%$1.1B #2

$7.36-0.74%$474.6M #3

ArriVent BioPharma, Inc. Common Stock

$30.49+0.10%$1.4B #4

Day One Biopharmaceuticals, Inc.

$21.53+0.00%$2.2B #5

Ginkgo Bioworks Holdings, Inc.

$8.16-0.12%$533.0M #6

Geron Corporation

$1.14-1.71%$731.3M

股票表现

1D+2.83%

1W-5.80%

1M-13.19%

3M-5.43%

YTD+7.35%

1Y+242.13%

5Y-20.53%

关于 Monte Rosa Therapeutics, Inc.

CEOMarkus Warmuth

IPO DateJun 24, 2021

Employees142

CountryUS

Websitemonterosatx.com

Monte Rosa Therapeutics, Inc. a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade ther…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Monte Rosa Therapeutics, Inc.（GLUE）是 Biotechnology 行业的 Healthcare 类公司，于 Jun 24, 2021 在 NASDAQ 上市。截至最近交易日，GLUE 股价为 $16.84，市值约为 $1.1B。过去12个月累计回报 +242.13%，年初至今回报 +7.35%。

根据 9 位华尔街分析师，Monte Rosa Therapeutics, Inc. 股票共识评级为Buy，12个月平均目标价为 $31.75。2025 财年 Monte Rosa Therapeutics, Inc. 营收 $123.7M，净利润 -$38.6M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Monte Rosa Therapeutics, Inc.（GLUE）股价为 $16.84，在 NASDAQ 上市，52周区间为 $4.12 – $25.77。

GLUE 最新股价GLUE quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议